Drug Research
FUJIFILM Diosynth Biotechnologies Begins Production of Two COVID-19 Vaccines Candidates at Texas Facility
FUJIFILM Diosynth Biotechnologies and the Texas A&M University System Center for Innovation in Advanced Development & Manufacturing (CIADM) announced that production has begun in Texas on two different COVID-19 vaccine candidates with support from the U.S. government to meet...
Drug Research
CEVEC Pharma grants Biogen rights to its proprietary Elevecta Technology for manufacturing of gene therapy products
CEVEC Pharmaceuticals GmbH announced the signing of a license agreement with Biogen Inc. for the use of CEVEC’s proprietary ELEVECTA® Technology for the manufacturing of adeno-associated virus (AAV) vectors for gene therapy applications.
Under the terms of the agreement, CEVEC...
Drug Research
Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors
Kite, a Gilead Company, and Oxford BioTherapeutics Ltd. (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (IO) and antibody-drug conjugate (ADC)-based therapies, announced that the companies have entered into a research collaboration to evaluate five novel...
Drug Research
Servier and X-Chem Announce Drug Discovery Collaboration in Neurological Diseases
Servier, a global pharmaceutical Group and X-Chem, Inc., a privately held drug discovery company announced a partnership to identify and develop novel small molecules for the treatment of neurological disorders.
Under the terms of the multi-target agreement, X-Chem will utilize...
Drug Research
WuXi STA’s Integrated CMC Platform Supports InnoCare Orelabrutinib Approved by NMPA
STA Pharmaceutical, a WuXi AppTec Company (WuXi STA), announces their partner Innocare has received approval by the National Medical Products Administration of China (NMPA) for Orelabrutinib. Under the Marketing Authorization Holder (MAH) policy, WuXi STA provided an integrated and...
Drug Research
INOVIO, Advaccine Enter Exclusive COVID-19 DNA Vax Pact
INOVIO, a biotechnology company focused on precisely designed DNA medicines to treat and prevent infectious diseases and cancer, and Advaccine Biopharmaceuticals Suzhou, an emerging biotech company with next-gen technology in vaccines, have entered into a collaboration and license agreement...
Drug Research
Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804
Incyte and Cellenkos, Inc., a privately held, clinical stage biotech company, announced a development collaboration to investigate the combination of ruxolitinib (Jakafi®) and CK0804, Cellenkos’ cryopreserved CXCR4 enriched, allogeneic, umbilical cord blood-derived T-regulatory cells, in patients with myelofibrosis (MF)....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
